Simultaneously, aberrant glucagon-like peptide-1 (GLP-1) production does not adequately stimulate insulin release in a glucose-concentration-dependent manner, resulting in heightened insulin resistance (IR) [90,91]. The gene discussed is GLP1R; the disease is Insulin resistance.